MariMed Inc. (OTCMKTS:MRMD) Short Interest Down 84.0% in May

MariMed Inc. (OTCMKTS:MRMD) was the target of a large decrease in short interest in May. As of May 15th, there was short interest totaling 3,327 shares, a decrease of 84.0% from the April 30th total of 20,807 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average trading volume of 1,290,557 shares, the short-interest ratio is presently 0.0 days.

MariMed Trading Down 3.1%

MRMD stock traded down $0.00 during mid-day trading on Friday, reaching $0.08. The company had a trading volume of 452,855 shares, compared to its average volume of 612,455. The company has a debt-to-equity ratio of 1.67, a current ratio of 0.95 and a quick ratio of 0.34. The company has a market capitalization of $31.14 million, a PE ratio of -2.60 and a beta of 1.33. The firm has a 50 day moving average of $0.08 and a 200 day moving average of $0.08. MariMed has a 12 month low of $0.06 and a 12 month high of $0.23.

MariMed (OTCMKTS:MRMD) last issued its earnings results on Wednesday, May 13th. The company reported ($0.01) EPS for the quarter, hitting analysts’ consensus estimates of ($0.01). The business had revenue of $39.48 million for the quarter, compared to the consensus estimate of $38.75 million. MariMed had a negative net margin of 7.82% and a negative return on equity of 5.00%. On average, equities analysts predict that MariMed will post -0.04 earnings per share for the current fiscal year.

About MariMed

MariMed Inc is a multi‐state cannabis company focused on the development, ownership and operation of regulated facilities for the medical and adult‐use cannabis markets. Headquartered in New Bedford, Massachusetts, the company cultivates, processes and dispenses cannabis through an integrated business model that encompasses cultivation, formulation, manufacturing and retail operations. MariMed operates under its own licensed brands and through strategic partnerships to expand its presence across the United States.

The company’s product portfolio includes branded flower, pre‐rolls, vaporizer cartridges, tinctures, edibles and topicals designed to meet a range of consumer and patient needs.